Endocyte
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Endocyte generated cash of -$33,658,654, which is more than the previous year. Cash used in financing activities reached the amount of $5,621,796 last year. Net change in cash is therefore -$12,669,062.
Cash Flow
| 2013 | -51.08M | 69.29M | 644.93K |
|---|---|---|---|
| 2014 | -42.20M | -68.56M | 103.49M |
| 2015 | -32.21M | 1.49M | 627.01K |
| 2016 | -34.65M | 50.11M | 328.46K |
| 2017 | -33.65M | 15.36M | 5.62M |
ECYT Cash Flow Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Cash at beginning of period | 31.22M | 15.43M | 45.53M | 52.84M | 33.99M |
Operating activities | |||||
Net income | -55.06M | -43.88M | -41.26M | 5.45M | -18.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 922.67K | 919.80K | 886.71K | 857.05K | 674.72K |
Stock-based compensation expense | 4.17M | 9.32M | 6.92M | 8.02M | 6.05M |
| Deferred income tax benefit | 4.17M | 9.32M | 6.92M | 8.02M | 6.05M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.02M | -252.60K | -60.71K | -3.70M | -386.24K |
Cash generated by operating activities | -33.65M | -34.65M | -32.21M | -42.20M | -51.08M |
Investing activities | |||||
Purchases Of Investments | -106.72M | -139.93M | -86.28M | -149.37M | -125.02M |
Investments In Property Plant And Equipment | -12.85M | -713.83K | -341.61K | -1.50M | -827.83K |
Acquisitions Net | 12.77M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 15.36M | 50.11M | 1.49M | -68.56M | 69.29M |
Financing activities | |||||
Common Stock Issued | 72.11K | 231.85K | 305.00K | 102.20M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -94.62K | -164.47K | -57.27K | -3.81K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 5.62M | 328.46K | 627.01K | 103.49M | 644.93K |
Net Change In Cash | -12.66M | 15.79M | -30.10M | -7.31M | 18.85M |
Cash at end of period | 18.55M | 31.22M | 15.43M | 45.53M | 52.84M |